Press Releases
Quaker Chemical Announces Fourth Quarter And Full Year 2016 Results
The Company's current quarter earnings per diluted share increased to
Mr. Barry continued, "2016 was our seventh consecutive year of adjusted EBITDA and non-GAAP earnings growth. The 5% growth in full year adjusted EBITDA was achieved despite foreign exchange negatively impacting our bottom line by 4%. Looking forward, we expect foreign exchange to continue to be a headwind. However, we remain committed to our strategy and believe our ability to take market share and leverage our past acquisitions will continue to help offset market challenges. Our 2017 plans indicate growth in both the top and bottom lines, despite expected currency headwinds, with profit growth in all regions. Overall, I continue to remain confident in our future and expect 2017 to be another good year for Quaker, as we expect to increase non-GAAP earnings and adjusted EBITDA for the eighth consecutive year."
Fourth Quarter of 2016 Summary
Net sales in the fourth quarter of 2016 were
Gross profit in the fourth quarter of 2016 increased
SG&A increased
The Company had restructuring expenses of
Operating income in the fourth quarter of 2016 was
Other income increased
Interest expense was relatively consistent on comparable average borrowings outstanding in both quarters. Interest income was
The Company's effective tax rates for the fourth quarters of 2016 and 2015 were 17.3% and 16.5%, respectively. The Company's fourth quarter of 2016 effective tax rate reflects the receipt of a concessionary tax rate in one of its subsidiaries, which allowed the Company to adjust the subsidiaries tax rate from 25%, used in the first nine months of 2016, to 15% for the full year. The Company recorded the cumulative full year benefit of the lower rate in the fourth quarter of 2016. In the fourth quarter of 2015, the effective tax rate reflected the accelerated recognition of certain tax-related incentives due to changes in local tax regulations, adjustments related to previous years' tax estimates, and the overall mix of earnings between higher and lower tax jurisdictions.
Equity in net income of associated companies ("equity income") decreased
The Company recognized a minimal impact to net income from its
Changes in foreign exchange rates negatively impacted the Company's fourth quarter of 2016 net income by approximately 5%, or
Full Year 2016 Summary
Net sales in 2016 were
Gross profit in 2016 increased
The SG&A decrease of
As noted above, the Company had restructuring expenses of
Operating income in 2016 was
Other income was
Interest expense was
The Company's effective tax rates for 2016 and 2015 were 27.6% and 25.3%, respectively. The primary contributors to the difference between the Company's effective tax rates in 2016 and 2015 were certain one-time items recorded during 2015, including the accelerated recognition of certain tax-related incentives and adjustments related to previous years' tax estimates, noted above. Going into 2017, we expect the full year effective tax rate will be between 28% and 30%.
Equity income in 2016 increased
The Company had a
Changes in foreign exchange rates, excluding the currency conversion impacts of the Venezuelan bolivar fuerte noted above, negatively impacted the Company's 2016 net income by approximately 4%, or
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of
Non-GAAP Measures
Included in this public release are two non-GAAP (unaudited) financial measures: non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. The following tables reconcile non-GAAP earnings per diluted share (unaudited) and adjusted EBITDA (unaudited) to their most directly comparable GAAP financial measures:
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||
2016 |
2015 |
2016 |
2015 |
||||
GAAP earnings per diluted share attributable to |
$ 1.31 |
$ 0.86 |
$ 4.63 |
$ 3.84 |
|||
Equity income in a captive insurance company per |
(0.06) |
(0.07) |
(0.13) |
(0.16) |
|||
Restructuring (credit) expense per diluted share |
(0.02) |
0.36 |
(0.02) |
0.36 |
|||
Certain uncommon transaction-related expenses |
0.03 |
— |
0.11 |
0.15 |
|||
Customer bankruptcy costs per diluted share |
— |
0.01 |
— |
0.02 |
|||
Cost streamlining initiatives per diluted share |
— |
— |
— |
0.01 |
|||
Currency conversion impact of the Venezuelan |
— |
— |
0.01 |
0.21 |
|||
Non-GAAP earnings per diluted share |
$ 1.26 |
$ 1.16 |
$ 4.60 |
$ 4.43 |
|||
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||
2016 |
2015 |
2016 |
2015 |
||||
Net income attributable to Quaker Chemical |
$ 17,434 |
$ 11,393 |
$ 61,403 |
$ 51,180 |
|||
Depreciation and amortization |
4,778 |
4,979 |
19,566 |
19,206 |
|||
Interest expense |
663 |
694 |
2,889 |
2,585 |
|||
Taxes on income before equity in net income |
3,562 |
2,161 |
23,226 |
17,785 |
|||
Equity income in a captive insurance |
(736) |
(857) |
(1,688) |
(2,078) |
|||
Restructuring (credit) expense |
(439) |
6,790 |
(439) |
6,790 |
|||
Certain uncommon transaction-related |
374 |
— |
1,531 |
2,813 |
|||
Customer bankruptcy costs |
— |
149 |
— |
328 |
|||
Cost streamlining initiatives |
— |
— |
— |
173 |
|||
Currency conversion impact of the Venezuelan |
— |
— |
88 |
2,806 |
|||
Adjusted EBITDA |
$ 25,636 |
$ 25,309 |
$ 106,576 |
$ 101,588 |
|||
Adjusted EBITDA margin (%) |
13.4% |
13.8% |
14.3% |
13.8% |
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
|||||||
Consolidated Statements of Income |
|||||||
(Dollars in thousands, except share and per share data) |
|||||||
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||
2016 |
2015 |
2016 |
2015 |
||||
Net sales |
$ 191,245 |
$ 183,275 |
$ 746,665 |
$ 737,555 |
|||
Cost of goods sold |
121,541 |
114,509 |
467,072 |
460,515 |
|||
Gross profit |
69,704 |
68,766 |
279,593 |
277,040 |
|||
% |
36.4% |
37.5% |
37.4% |
37.6% |
|||
Selling, general and administrative expenses |
49,758 |
48,753 |
196,981 |
198,990 |
|||
Restructuring and related activities |
(439) |
6,790 |
(439) |
6,790 |
|||
Operating income |
20,385 |
13,223 |
83,051 |
71,260 |
|||
% |
10.7% |
7.2% |
11.1% |
9.7% |
|||
Other income (expense), net |
319 |
28 |
1,810 |
(69) |
|||
Interest expense |
(663) |
(694) |
(2,889) |
(2,585) |
|||
Interest income |
593 |
507 |
2,037 |
1,624 |
|||
Income before taxes and equity in net income of associated companies |
20,634 |
13,064 |
84,009 |
70,230 |
|||
Taxes on income before equity in net income of associated companies |
3,562 |
2,161 |
23,226 |
17,785 |
|||
Income before equity in net income of associated companies |
17,072 |
10,903 |
60,783 |
52,445 |
|||
Equity in net income of associated companies |
867 |
949 |
2,256 |
261 |
|||
Net income |
17,939 |
11,852 |
63,039 |
52,706 |
|||
Less: Net income attributable to noncontrolling interest |
505 |
459 |
1,636 |
1,526 |
|||
Net income attributable to Quaker Chemical Corporation |
$ 17,434 |
$ 11,393 |
$ 61,403 |
$ 51,180 |
|||
% |
9.1% |
6.2% |
8.2% |
6.9% |
|||
Share and per share data: |
|||||||
Basic weighted average common shares outstanding |
13,157,411 |
13,180,364 |
13,136,138 |
13,199,630 |
|||
Diluted weighted average common shares outstanding |
13,198,611 |
13,193,659 |
13,160,469 |
13,214,849 |
|||
Net income attributable to Quaker Chemical Corporation Common |
$ 1.31 |
$ 0.86 |
$ 4.64 |
$ 3.84 |
|||
Net income attributable to Quaker Chemical Corporation Common |
$ 1.31 |
$ 0.86 |
$ 4.63 |
$ 3.84 |
Quaker Chemical Corporation |
|||
Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value and share amounts) |
|||
December 31, |
|||
2016 |
2015 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 88,818 |
$ 81,053 |
|
Accounts receivable, net |
195,225 |
188,297 |
|
Inventories, net |
77,082 |
75,099 |
|
Prepaid expenses and other current assets |
15,343 |
13,582 |
|
Total current assets |
376,468 |
358,031 |
|
Property, plant and equipment, net |
85,734 |
87,619 |
|
Goodwill |
80,804 |
79,111 |
|
Other intangible assets, net |
73,071 |
73,287 |
|
Investments in associated companies |
22,817 |
20,354 |
|
Non-current deferred tax assets |
24,382 |
30,107 |
|
Other assets |
28,752 |
32,218 |
|
Total assets |
$ 692,028 |
$ 680,727 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 707 |
$ 662 |
|
Accounts payable |
77,583 |
67,291 |
|
Dividends payable |
4,581 |
4,252 |
|
Accrued compensation |
19,356 |
19,166 |
|
Accrued restructuring |
670 |
6,303 |
|
Accrued pension and postretirement benefits |
1,086 |
1,144 |
|
Other current liabilities |
23,428 |
25,696 |
|
Total current liabilities |
127,411 |
124,514 |
|
Long-term debt |
65,769 |
81,439 |
|
Non-current deferred tax liabilities |
12,008 |
10,258 |
|
Non-current accrued pension and postretirement benefits |
38,348 |
40,689 |
|
Other non-current liabilities |
35,886 |
42,584 |
|
Total liabilities |
279,422 |
299,484 |
|
Equity |
|||
Common stock, $1 par value; authorized 30,000,000 shares; issued |
13,278 |
13,288 |
|
Capital in excess of par value |
112,475 |
106,333 |
|
Retained earnings |
364,414 |
326,740 |
|
Accumulated other comprehensive loss |
(87,407) |
(73,316) |
|
Total Quaker shareholders' equity |
402,760 |
373,045 |
|
Noncontrolling interest |
9,846 |
8,198 |
|
Total equity |
412,606 |
381,243 |
|
Total liabilities and equity |
$ 692,028 |
$ 680,727 |
|
Quaker Chemical Corporation |
|||
Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
Twelve Months Ended December 31, |
|||
2016 |
2015 |
||
Cash flows from operating activities |
|||
Net income |
$ 63,039 |
$ 52,706 |
|
Adjustments to reconcile net income to net cash provided by |
|||
Depreciation |
12,557 |
12,395 |
|
Amortization |
7,009 |
6,811 |
|
Equity in undistributed (earnings) losses of associated |
(1,969) |
578 |
|
Deferred income taxes |
5,488 |
(2,401) |
|
Uncertain tax positions (non-deferred portion) |
(3,206) |
(1,122) |
|
Deferred compensation and other, net |
(424) |
14 |
|
Stock-based compensation |
6,349 |
5,919 |
|
Restructuring and related activities |
(439) |
6,790 |
|
Gain on disposal of property, plant and equipment and |
(18) |
(12) |
|
Insurance settlement realized |
(1,023) |
(760) |
|
Pension and other postretirement benefits |
(3,420) |
2,591 |
|
(Decrease) increase in cash from changes in current assets |
|||
Accounts receivable |
(11,705) |
(188) |
|
Inventories |
(1,870) |
1,292 |
|
Prepaid expenses and other current assets |
(703) |
(721) |
|
Accounts payable and accrued liabilities |
14,566 |
(9,040) |
|
Change in restructuring liabilities |
(5,252) |
(490) |
|
Estimated taxes on income |
(5,226) |
(930) |
|
Net cash provided by operating activities |
73,753 |
73,432 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(9,954) |
(11,033) |
|
Payments related to acquisitions, net of cash acquired |
(15,024) |
(24,058) |
|
Proceeds from disposition of assets |
186 |
135 |
|
Insurance settlement interest earned |
32 |
35 |
|
Change in restricted cash, net |
991 |
725 |
|
Net cash used in investing activities |
(23,769) |
(34,196) |
|
Cash flows from financing activities |
|||
Proceeds from long-term debt |
- |
6,163 |
|
Repayments of long-term debt |
(14,513) |
(477) |
|
Dividends paid |
(17,625) |
(16,513) |
|
Stock options exercised, other |
(811) |
1,048 |
|
Payments for repurchase of common stock |
(5,859) |
(7,276) |
|
Excess tax benefit related to stock option exercises |
678 |
384 |
|
Payment of acquisition-related liabilities |
- |
(226) |
|
Net cash used in financing activities |
(38,130) |
(16,897) |
|
Effect of exchange rate changes on cash |
(4,089) |
(6,017) |
|
Net increase in cash and cash equivalents |
7,765 |
16,322 |
|
Cash and cash equivalents at beginning of period |
81,053 |
64,731 |
|
Cash and cash equivalents at end of period |
$ 88,818 |
$ 81,053 |
|
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quaker-chemical-announces-fourth-quarter-and-full-year-2016-results-300415125.html
SOURCE
Mary Dean Hall, Vice President, Chief Financial Officer and Treasurer, Hallm@quakerchem.com, T. 610.832.4160